Featured in Bio-ingenieus, the magazine of the Faculty of Bioscience Engineering at KU Leuven, the research of the Lammertyn Lab highlights the growing role of biosensors and microfluidics in healthcare innovation. The article features the (i)SIMPLE technology developed within the FORTIFIEDx project, targeting infectious diseases such as HIV and Ebola.
Biosensors enable rapid and accurate detection of diseases using only a small sample of blood, saliva, or other bodily fluids. By combining nanotechnology, microfluidics, and advanced bio-recognition elements, these devices can deliver results within minutes, reducing the need for complex laboratory procedures.
Building on this expertise, the team has developed micro-sampling technologies that allow precise collection and stabilization of capillary blood, supporting at-home testing solutions and remote diagnostics. In parallel, advanced lab-on-a-chip systems and self-powered microfluidic patches are being explored for the detection of infectious diseases, including viral infections.
This work reflects a broader shift toward accessible, decentralized healthcare solutions. Within FORTIFIEDx, such innovations demonstrate how advanced microfluidic technologies can contribute to more efficient and scalable diagnostics for global health challenges.
